SUB-SAHARAN AFRICA
Within the Sub-Saharan Africa business local brands have strong brand equity and continue to contribute positively to Aspen’s leading presence in the South African market. We also supply OTC brands in various home markets outside South Africa, mainly in Namibia, Botswana, Tanzania, Kenya, Nigeria, Ghana and Uganda.
Key Countries
Botswana
Kenya
Namibia
South Africa
Tanzania

- The South African private pharmaceutical sector was valued at
R45,4 billion for the MAT period July 2020. - In South Africa, four out of the top 10 brands in the private sector were Aspen (and Ethicare) products.
- Aspen (and Ethicare) is ranked as the number one pharmaceutical company in the South African private sector with an 11,9% share by value.
* South Africa only, rest of sub-Saharan Africa (“SSA”) not covered by IQVIA.
Source: IQVIA – July 2020
STATISTICS
Number of products launched:
22
(2019: 22)
Average staff turnover†:
10%
(2019: 11%)
Number of product recalls:
5
(2019: 5)
Number of work-related fatalities:
Nil
(2019: Nil)
Number of permanent employees | ||
4 034June 2020 |
4 167June 2019 |
*Rate excludes employees transferred in Nutritionals disposal.
Revenue | 2020 R’million |
2019 (CER) R’million |
Change % |
||||
---|---|---|---|---|---|---|---|
Regional Brands | 7 070 | 6 691 | 6 | ||||
Sterile Focus Brands | 124 | 119 | 4 | ||||
Anaesthetics Brands | 118 | 112 | 5 | ||||
Thrombosis Brands | 6 | 7 | (14) | ||||
Total Commercial Pharmaceuticals | 7 194 | 6 810 | 6 | ||||
Manufacturing | 686 | 613 | 12 | ||||
FDF | 314 | 253 | 24 | ||||
API | 372 | 360 | 3 | ||||
Total | 7 880 | 7 423 | 6 |
Note: Commercial Pharmaceuticals revenue by customer geography and anufacturing revenue by place of manufacture.